RONCATO, ROSSANA
 Distribuzione geografica
Continente #
NA - Nord America 1.074
AS - Asia 419
EU - Europa 304
AF - Africa 110
SA - Sud America 98
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 11
Totale 2.033
Nazione #
US - Stati Uniti d'America 1.024
SG - Singapore 120
CN - Cina 119
IT - Italia 66
BR - Brasile 61
HK - Hong Kong 53
DE - Germania 36
PL - Polonia 28
FI - Finlandia 20
GB - Regno Unito 15
RU - Federazione Russa 15
FR - Francia 12
NL - Olanda 10
AE - Emirati Arabi Uniti 8
IN - India 8
TW - Taiwan 8
UA - Ucraina 8
VN - Vietnam 8
AT - Austria 7
IE - Irlanda 7
MN - Mongolia 7
ZA - Sudafrica 7
AM - Armenia 6
BE - Belgio 6
BY - Bielorussia 6
CW - ???statistics.table.value.countryCode.CW??? 6
DZ - Algeria 6
PH - Filippine 6
TH - Thailandia 6
UY - Uruguay 6
VE - Venezuela 6
AR - Argentina 5
CA - Canada 5
CL - Cile 5
EC - Ecuador 5
ES - Italia 5
GN - Guinea 5
GT - Guatemala 5
HR - Croazia 5
ID - Indonesia 5
ME - Montenegro 5
MW - Malawi 5
MX - Messico 5
NC - Nuova Caledonia 5
PR - Porto Rico 5
UG - Uganda 5
XK - ???statistics.table.value.countryCode.XK??? 5
ZM - Zambia 5
AD - Andorra 4
AU - Australia 4
BD - Bangladesh 4
BG - Bulgaria 4
CG - Congo 4
EE - Estonia 4
KH - Cambogia 4
KR - Corea 4
LY - Libia 4
MA - Marocco 4
NZ - Nuova Zelanda 4
PA - Panama 4
PK - Pakistan 4
SE - Svezia 4
TR - Turchia 4
TZ - Tanzania 4
BF - Burkina Faso 3
BZ - Belize 3
CM - Camerun 3
CO - Colombia 3
CR - Costa Rica 3
CY - Cipro 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GH - Ghana 3
HT - Haiti 3
HU - Ungheria 3
IL - Israele 3
IR - Iran 3
JP - Giappone 3
KE - Kenya 3
KZ - Kazakistan 3
MD - Moldavia 3
MU - Mauritius 3
MY - Malesia 3
NA - Namibia 3
NE - Niger 3
PG - Papua Nuova Guinea 3
RE - Reunion 3
TJ - Tagikistan 3
TN - Tunisia 3
YE - Yemen 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BJ - Benin 2
BO - Bolivia 2
BS - Bahamas 2
CD - Congo 2
CH - Svizzera 2
CI - Costa d'Avorio 2
Totale 1.948
Città #
Fairfield 149
Ashburn 141
Chandler 94
Singapore 77
Woodbridge 68
Cambridge 63
Seattle 52
Hong Kong 51
Beijing 44
Houston 40
Wilmington 35
Ann Arbor 31
Santa Clara 26
Boardman 19
Bytom 19
Medford 18
Munich 18
Princeton 18
New York 16
Los Angeles 15
Des Moines 14
Padova 13
London 11
Chicago 9
San Diego 9
Helsinki 8
Turku 8
Jinan 7
Ulan Bator 7
Buffalo 6
Cagliari 6
Dublin 6
Montevideo 6
Philadelphia 6
Roxbury 6
Albignasego 5
Conakry 5
Falkenstein 5
Kampala 5
Lusaka 5
Milan 5
Nanjing 5
Noumea 5
Warsaw 5
Willemstad 5
Yerevan 5
Abu Dhabi 4
Andorra la Vella 4
Boston 4
Council Bluffs 4
Madrid 4
Minsk 4
Panama City 4
Podgorica 4
San Juan 4
Accra 3
Atglen 3
Bangkok 3
Charlotte 3
Dar es Salaam 3
Dushanbe 3
George Town 3
Guayaquil 3
Ho Chi Minh City 3
Istanbul 3
Lilongwe 3
Nairobi 3
Niamey 3
Ouagadougou 3
Phnom Penh 3
Port Moresby 3
Rio de Janeiro 3
San José 3
Shenyang 3
Sofia 3
São Paulo 3
Taichung 3
Taipei 3
Taizhou 3
Tampa 3
Vienna 3
Zagreb 3
Abidjan 2
Akureyri 2
Anápolis 2
Astana 2
Atlanta 2
Auckland 2
Bamako 2
Belize City 2
Blantyre 2
Brest 2
Caracas 2
Chisinau 2
Cotonou 2
Dakar 2
Dallas 2
Dhaka 2
Dili 2
Douala 2
Totale 1.324
Nome #
Cost evaluation of irinotecan-related toxicities associated with the UGT1A1*28 patient genotype 149
Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer 147
Pharmacogenomics of targeted agents for personalization of colorectal cancer treatment 138
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 134
FARMAPRICE: A Pharmacogenetic Clinical decision support system for precise and Cost-Effective Therapy 128
Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine 127
Il15ra and smad3 genetic variants predict overall survival in metastatic colorectal cancer patients treated with folfiri therapy: A new paradigm 116
PREEMPTIVE PHARMACOGENOMIC TESTING FOR PREVENTING ADVERSE DRUG REACTIONS (PREPARE): STATE OF ART AND PRELIMINARY RESULTS ON GENOTYPE ACTIONABILITY 115
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines 113
Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI 111
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 108
Development of an Integrated Health IT Platform for a Precision Medicine Setting 106
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-related gastrointestinal toxicity in metastatic colorectal cancer patients 105
Genetic biomarkers for hepatocellular cancer risk in a caucasian population. 104
Therapeutic drug monitoring for the cancer patient: challenges and opportunities 99
Innovative strategies for tailoring therapy in cancer patient pharmacogenetics and therapy personalization in metastatic colorectal cancer patients treated with irinotecan 90
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy 85
DEVELOPMENT OF AN INTEGRATED HEALTH IT PLATFORM FOR A PRECISE AND COST-EFFECTIVE THERAPY IN ONCOLOGY 79
Totale 2.054
Categoria #
all - tutte 7.505
article - articoli 6.726
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.231


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 4 52 4 4 18 27 4 6 10
2021/2022246 24 46 27 8 3 7 20 24 5 10 24 48
2022/2023169 31 23 0 20 29 30 1 7 12 1 12 3
2023/2024164 2 10 17 13 10 41 11 17 3 12 14 14
2024/2025453 11 16 16 25 49 18 22 49 19 26 87 115
2025/2026611 117 141 217 136 0 0 0 0 0 0 0 0
Totale 2.054